No Detail Found!

Efficacy and safety of drug-eluting balloon vs drug-eluting stents in the treatment of in-stent restenosis

Author(s)
AYAZ S Department of Cardiology, Peshawar Institute of Cardiology, Peshawar, Pakistan
AKBAR F Department of Cardiology, Peshawar Institute of Cardiology, Peshawar, Pakistan
ARA U Department of Cardiology, Peshawar Institute of Cardiology, Peshawar, Pakistan
HUSSAIN K College of Pharmacy, ISRA University Hyderabad, Sindh, Pakistan
OMER AM Department of Cardiology, Islamic International Medical College, Rawalpindi, Pakistan
GILANI SRA Allama Iqbal Medical College, Jinnah Hospital Lahore, Pakistan
Abstract
The in-stent restenosis (ISR) treatment remains related to the higher recurrence rate. This comparative study aimed to compare the effectiveness and safety of drug-eluting balloon (DEB) vs drug-eluting stents (DES) in the in-stent restenosis treatment. Sixty-four patients who underwent PCI for ISR in the Department of Cardiology, Peshawar Institute of Cardiology, Peshawar, from October 2022 to March 2023 were enrolled. Patients were distributed as Group-I patients treated with drug-eluting balloons (n=28, 43.8%) and Group-II patients treated with drug-eluting stents (n=36, 56.2%). Clinical outcomes were recorded. Target lesion revascularization (TLR), myocardial infarction, and cardiac death were different endpoints of major adverse cardiac events (MACE). The overall mean age was 64.12±4.65 years. The incidence of MACEs in groups I and II was 14.3% (n=4) and 16.7% (n=6) respectively. Group I and II had insignificant associations regarding baseline characteristics except for MI's prior history. TLR was more frequent in the DEB group (7.1%, n=2) than in the DES group (2.8%, n=1). The incidence of diabetes, hypertension, current smokers, and previous myocardial infarction in Group I vs. Group II was 42.9% vs. 38.9%, 64.3% vs. 47.2%, 14.3% vs. 22.2%, and 17.9% vs. 47.2%, respectively. Drug-eluting balloons showed effective results for PCI, a viable alternative to placing drug-eluting stents for the coronary in-stent restenosis treatment.
Publication Details
Page(s) 1-5
Published Journal: Biological and Clinical Sciences Research Journal, Volume: 4, Issue: 1, Year: 2023

Request the full text from PASTIC

Keywords
Efficacy, Drug-Eluting Balloon, Drug-Eluting Stents, In-Stent Restenosis
0

Citations

0

Downloads

67

Views